<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <title>How It Works | LiquidMammo™</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta
    name="description"
    content="How LiquidMammo™ works: a non-invasive microRNA blood test designed to complement breast cancer screening, especially in dense breasts."
  />

  <!-- Styles -->
  assets/css/styles.css

  <!-- Favicon -->
  favicon.png
</head>

<body>

<header class="container">
  <nav>index.html← Home</a></nav>
</header>

<main class="container">

  <h1>How LiquidMammo™ Works</h1>

  <!-- Intro -->
  <section class="section-tight">
    <p>
      LiquidMammo™ is being developed as a <strong>microRNA-based liquid biopsy</strong> that provides a
      <strong>biological signal</strong> of breast cancer risk to complement mammography—especially in
      <strong>dense-breasted</strong> individuals where imaging sensitivity is reduced.
    </p>

    <p class="notice" style="margin-top:14px;">
      LiquidMammo is currently in development as a <strong>CLIA Laboratory Developed Test (LDT)</strong> and
      is <strong>not yet FDA‑cleared/approved</strong>.
    </p>
  </section>

  <!-- Why a liquid biopsy matters -->
  <section class="panel-light section-tight">
    <h2>Why a blood‑based test?</h2>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));margin-top:18px;">
      <div class="card-mini">
        <h4>Density-independent</h4>
        <p class="small">
          microRNA signals are not affected by tissue density, eliminating one of the biggest limitations
          of mammography for many women.
        </p>
      </div>

      <div class="card-mini">
        <h4>Early biological changes</h4>
        <p class="small">
          microRNAs involved in cancer pathways can shift <em>before</em> structural changes become visible
          on imaging.
        </p>
      </div>

      <div class="card-mini">
        <h4>Simple &amp; non-invasive</h4>
        <p class="small">
          Only a blood draw—no radiation, no compression, no specialized scheduling.
        </p>
      </div>
    </div>
  </section>

  <!-- Main workflow -->
  <section class="section-tight">
    <h2>The process</h2>
    <p>
      LiquidMammo is designed to integrate easily into routine clinical workflows. Here’s how the process works:
    </p>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));margin-top:22px;">
      
      <div class="card-mini">
        <h4>1 — Order placed by clinician</h4>
        <p class="small">
          A clinician orders the test during a routine visit. No fasting or preparation is required.
          Phlebotomy can occur in‑clinic or via standard partner labs.
        </p>
      </div>

      <div class="card-mini">
        <h4>2 — Blood draw &amp; microRNA stabilization</h4>
        <p class="small">
          A small blood sample is collected and stabilized via standard laboratory tubes to preserve
          <span class="scientific-term">microRNA</span> integrity for analysis.
        </p>
      </div>

      <div class="card-mini">
        <h4>3 — Laboratory analysis</h4>
        <p class="small">
          Plasma is processed under controlled SOPs. A multi-marker microRNA signature associated with
          breast cancer pathways is quantified and analyzed.
        </p>
      </div>

      <div class="card-mini">
        <h4>4 — Actionable report to clinician</h4>
        <p class="small">
          Your clinician receives a structured result with interpretation and recommended next steps,
          such as routine screening or diagnostic follow‑up if indicated.
        </p>
      </div>

    </div>
  </section>

  <!-- Biological mechanism -->
  <section class="panel-light section-tight">
    <h2>The science inside the test</h2>

    <div class="grid" style="grid-template-columns:repeat(auto-fit,minmax(260px,1fr));margin-top:16px;">

      <div class="card-mini">
        <h4>microRNA dysregulation</h4>
        <p class="small">
          Breast tumors release or alter levels of specific microRNAs involved in oncogenic pathways
          (proliferation, apoptosis, immune evasion).
        </p>
      </div>

      <div class="card-mini">
        <h4>Signal detected in blood</h4>
        <p class="small">
          These circulating microRNAs can be measured in plasma, generating a molecular pattern that
          distinguishes cancer from non‑cancer states.
        </p>
      </div>

      <div class="card-mini">
        <h4>Multi‑marker signature</h4>
        <p class="small">
          LiquidMammo uses a combination of markers—not a single microRNA—to improve sensitivity,
          specificity, and robustness across populations.
        </p>
      </div>
    </div>
  </section>

  <!-- Intended use -->
  <section class="section-tight">
    <h2>Intended use</h2>
    <p>
      LiquidMammo is being designed as a <strong>supplemental screening tool</strong> to help clinicians
      determine when additional imaging or closer monitoring may be appropriate. It is not intended to replace
      mammography or clinical breast exams.
    </p>
  </section>

  <!-- CTA -->
  <section class="section">
    <h2>Learn more or get involved</h2>

    <div style="margin-top:16px;display:flex;gap:12px;flex-wrap:wrap;">
      patients.html#patientsInformation for Patients</a>
      clinicians.html#enrollClinician Enrollment</a>
      contact.html#inquiryContact Us</a>
    </div>
  </section>

</main>

<footer>
  <div class="container footer-grid">
    <div>
      <strong>LiquidMammo™</strong><br/>
      A test developed by MultiOmics Inc.
      <p class="footer-note">
        MultiOmics Inc. is headquartered in Washington, DC, and operates out of LabCentral,
        Cambridge, MA (MIT innovation ecosystem).
      </p>
    </div>

    <div class="footer-logo" style="justify-content:flex-end;text-align:right">
      assets/logos/multiomics-logo.png
      <div class="footer-note" style="line-height:1.2">Developed by<br/>MultiOmics Inc.</div>
    </div>
  </div>

  <div class="container footer-note">
    © <script>document.write(new Date().getFullYear())</script> MultiOmics Inc. •
    privacy.htmlPrivacy &amp; Compliance</a> •
    contact.htmlContact</a>
  </div>
</footer>

</body>
</html>

